journal
MENU ▼
Read by QxMD icon Read
search

Interventional Cardiology Clinics

journal
https://www.readbyqxmd.com/read/29526295/left-atrial-appendage-occlusion-for-stroke-prevention-in-patients-with-atrial-fibrillation
#1
EDITORIAL
Apostolos Tzikas
No abstract text is available yet for this article.
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526294/left-atrial-appendage-occlusion-shared-decision-making-and-comprehensive-atrial-fibrillation-management
#2
REVIEW
Michael H Hoskins, Anshul M Patel, David B DeLurgio
The epidemic of atrial fibrillation (AF) requires a comprehensive management strategy that uses the full force of available data and technology, including anticoagulation, ablative therapy, and left atrial appendage occlusion. Patient-centered care with an emphasis on shared decision-making is particularly relevant to the authors' understanding of the complexity of AF and has helped them tailor therapy in this ever-growing patient population.
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526293/left-atrial-appendage-occlusion-the-current-device-landscape-and-future-perspectives
#3
REVIEW
Ignacio Cruz-Gonzalez, Monica Fuertes-Barahona, Jose C Moreno-Samos, Rocio Gonzalez-Ferreiro, Yan Yin Lam, Pedro L Sanchez
Since the first percutaneous left atrial appendage occlusion (LAAO), many studies have shown the safety and efficacy of this technique to prevent embolic strokes in nonvavular atrial fibrillation. The design, characteristics, and clinical data of the most frequently used devices for LAAO are reviewed, including the Amplatzer cardiac plug and Amulet (Abbott Vascular), the Watchman (Boston Scientific), and the LARIAT device (SentreHEART). Similarly, newer closer devices, such as Ultraseal (Cardia), LAmbre (Lifetech), and Coherex WaveCrest (Johnson & Johnson), are also discussed...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526292/incidence-prevention-and-management-of-periprocedural-complications-of-left-atrial-appendage-occlusion
#4
REVIEW
Jay Thakkar, Dimitra Vasdeki, Apostolos Tzikas, Bernhard Meier, Jacqueline Saw
Major procedural complications related to left atrial appendage occlusion (LAAO) are relatively infrequent but may be associated with major morbidity and mortality. LAAO operators should be knowledgeable about these potential complications. Prompt recognition and treatment are necessary to avoid rapid deterioration and dire consequences. With stringent guidelines on operator training, competency requirements, and procedural-technical refinements, LAAO can be performed safely with low complication rates. This article focuses on commonly used devices, as well as prevention, treatment, and management of complications of LAOO...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526291/cardiac-computed-tomography-for-left-atrial-appendage-occlusion-acquisition-analysis-advantages-and-limitations
#5
REVIEW
Kasper Korsholm, Jesper Møller Jensen, Jens Erik Nielsen-Kudsk
Transcatheter left atrial appendage occlusion is increasingly used for stroke prevention in atrial fibrillation. The technique has proven effective and safe in randomized trials and multiple observational studies. The procedure is challenging due to the complex anatomy of the left atrial appendage; accurate cardiac imaging is essential for procedural guidance. Transesophageal echocardiography is the gold standard, but cardiac computed tomography (CT) has gained increasing interest within recent years. Cardiac CT offers high-resolution imaging allowing for preprocedural anatomic evaluation and device sizing, but may also be useful for exclusion of left atrial appendage thrombus, and follow-up assessment of residual peri-device leaks...
April 2018: Interventional cardiology clinics
https://www.readbyqxmd.com/read/29526290/echocardiographic-imaging-for-left-atrial-appendage-occlusion-transesophageal-echocardiography-and-intracardiac-echocardiographic-imaging
#6
REVIEW
Dee Dee Wang, Thomas J Forbes, James C Lee, Marvin H Eng
Left atrial appendage occlusion (LAAO) is a rapidly evolving technology. Multi-modality imaging and understanding of left atrial appendage anatomy are sure to advance. Two-dimensional and 3-dimensional transesophageal echocardiography with fluoroscopy are the mainstay for LAAO image-guided therapy. Key to successful LAAO is an understanding of the transseptal puncture, LAAO size selection for the device-specific landing zone, and postdeployment evaluation for leak and complications. With advancements in computed tomography, there may be a greater role for intracardiac echocardiographic imaging in specific types of LAAO anatomy and devices...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526289/the-amplatzer-amulet-device-technical-considerations-and-procedural-approach
#7
REVIEW
Nathan Messas, Reda Ibrahim
Percutaneous left atrial appendage occlusion (LAAO) for stroke prevention in patients with atrial fibrillation has significantly advanced in the past 2 decades. LAAO has emerged as a feasible and safe alternative to oral anticoagulants in patients who are deemed high risk for bleeding or are ineligible to receive anticoagulation. Herein, the authors review the main design features of the AMPLATZER Amulet device and describe step-by-step technical considerations for implantation of this LAAO device.
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526288/the-watchman-left-atrial-appendage-closure-device-technical-considerations-and-procedural-approach
#8
REVIEW
Matthew J Price
Randomized clinical trials have demonstrated that left atrial appendage (LAA) closure with the WATCHMAN device provides stroke prevention in nonvalvular atrial fibrillation while significantly reducing morality and major bleeding. Technical and procedural considerations are paramount for the therapeutic success. Maximizing procedural safety is critical. Optimal LAA sealing is required. Improvements in procedural technique and operator training have resulted in a marked reduction in adverse procedural events, which should increase the absolute long-term clinical benefit...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526287/anatomy-and-physiologic-roles-of-the-left-atrial-appendage-implications-for-endocardial-and-epicardial-device-closure
#9
REVIEW
Nicholas Y Tan, Omar Z Yasin, Alan Sugrue, Abdallah El Sabbagh, Thomas A Foley, Samuel J Asirvatham
The left atrial appendage has been implicated as a major nidus for thrombus formation, particularly in atrial fibrillation. This discovery has prompted substantial interest in the development of left atrial appendage exclusion devices aimed at decreasing systemic thromboembolism risk. Its deceptively simple appearance belies the remarkable complexity that characterizes its anatomy and physiology. We highlight the key anatomic features and variations of the left atrial appendage as well as its relationships with surrounding structures...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526286/indication-patient-selection-and-referral-pathways-for-left-atrial-appendage-closure
#10
REVIEW
Tawseef Dar, Mohit K Turagam, Bharath Yarlagadda, Mohmad Tantary, Seth H Sheldon, Dhanunjaya Lakkireddy
Left atrial appendage closure (LAAC) has emerged as a viable option for stroke prevention, especially in those intolerant of or not suitable for long-term oral anticoagulation therapy. This article describes the clinical characteristics, indications, and a proposed referral system for potential LAAC patients. Patient selection remains a challenge because of the paradox between the available randomized data on this intervention and the actual patient population who may gain maximum benefit. Further investigations comparing different LAAC devices with each other and with novel oral anticoagulants are needed...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526285/left-atrial-appendage-occlusion-data-update
#11
REVIEW
Matthew J Price
Resection of the left atrial appendage (LAA) to prevent recurrent arterial emboli in patients with atrial fibrillation was first suggested more than 60 years ago. Longer-term follow-up from randomized studies of the safety and efficacy of transcatheter LAA occlusion has recently been completed; data from large, observational cohorts are being reported. These recent data provide further insights into procedural safety with current techniques and the ability of LAA closure to reduce thromboembolic stroke compared with warfarin anticoagulation...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526284/history-of-percutaneous-left-atrial-appendage-occlusion-with-amplatzer-devices
#12
REVIEW
Bernhard Meier, Wim Stegink, Apostolos Tzikas
AMPLATZER devices preceded WATCHMAN occluder in 2002 for catheter-based left atrial appendage occlusion. The AMPLATZER technique facilitates simultaneous closure of atrial shunts using two devices through one gear. Randomized WATCHMAN follow-up data showed a mortality benefit over warfarin. AMPLATZER data make this likely valid for the strategy. Particularly young people with atrial fibrillation should be offered left atrial appendage occlusion because the risk is confined to the intervention and early postintervention period...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526283/a-history-of-left-atrial-appendage-occlusion
#13
REVIEW
David R Holmes, Robert S Schwartz, George G Latus, Robert A Van Tassel
A new era in antiembolic therapy has been initiated by the growing numbers of device-based therapies. Early concerns surrounding eliminating this enigmatic structure have not proven true. Other benefits are being further evaluated. Many other questions remain, such as whether there is a device-specific outcome effect or whether it is a class effect. Other questions include other devices, what head-to-head studies will show, and the impact of residual leak. Left atrial appendage using the Watchman ablation strategy can reduce cardioembolic stroke, with comparable or fewer adverse effects by device technology than obtained by long-term anticoagulation with its attendant bleeding risks...
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29526282/a-history-of-percutaneous-left-atrial-appendage-occlusion-with-the-plaato-device
#14
REVIEW
Heyder Omran, Apostolos Tzikas, Horst Sievert, Frederike Stock
Percutaneous left atrial appendage occlusion was introduced as an alternative method for prevention of thromboembolism in patients with nonvalvular atrial fibrillation after extensive animal work in 2001. The first device was named Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO) and patented by the company Appriva. The device was invented by Michael Lesh, MD.
April 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29157530/the-evolving-state-of-care-for-acute-pulmonary-embolism
#15
EDITORIAL
Jay Giri
No abstract text is available yet for this article.
January 2018: Interventional cardiology clinics
https://www.readbyqxmd.com/read/29157529/transcatheter-tricuspid-valve-intervention-addressing-an-unmet-clinical-need
#16
EDITORIAL
Azeem Latib
No abstract text is available yet for this article.
January 2018: Interventional Cardiology Clinics
https://www.readbyqxmd.com/read/29157528/catheter-based-embolectomy-for-acute-pulmonary-embolism-devices-technical-considerations-risks-and-benefits
#17
REVIEW
Wissam A Jaber, Michael C McDaniel
A significant number of patients with high-risk pulmonary embolism have contraindications to thrombolytic therapy. Catheter-based therapy may be helpful and consists of a multitude of catheters and techniques, some old and some new. Although there are few data supporting the use of any of these techniques, there has been a recent rise in interest and use of catheter-based pulmonary embolectomy. This text describes the contemporary devices used in pulmonary embolism treatment, discusses their challenges, and proposes some future directions...
January 2018: Interventional cardiology clinics
https://www.readbyqxmd.com/read/29157527/catheter-directed-therapy-for-pulmonary-embolism-patient-selection-and-technical-considerations
#18
REVIEW
Bedros Taslakian, Akhilesh K Sista
Acute pulmonary embolism (PE) is the third most common cause of death among hospitalized patients. Treatment escalation beyond anticoagulation therapy is necessary in patients with cardiogenic shock and may be of benefit in select normotensive patients with right heart strain. Percutaneous catheter-based techniques (catheter-directed mechanical thrombectomy, clot maceration, and/or pharmacologic thrombolysis) as an alternative or adjunct to systemic thrombolysis can rapidly debulk central clot in patients with shock...
January 2018: Interventional cardiology clinics
https://www.readbyqxmd.com/read/29157526/systemic-thrombolysis-for-pulmonary-embolism-evidence-patient-selection-and-protocols-for-management
#19
REVIEW
Hafeez Ul Hassan Virk, Sanjay Chatterjee, Partha Sardar, Chirag Bavishi, Jay Giri, Saurav Chatterjee
Acute pulmonary embolism presents a clinical challenge for optimal risk stratification. Although associated with significant morbidity and mortality at the population level, the spectrum of presentation in an individual patient varies from mild symptoms to cardiac arrest. Treatment options include anticoagulation, systemic thrombolysis, catheter-based interventions, and surgical embolectomy. In this article, an attempt is made to optimally identify patients who, based on available evidence, may benefit from systemic thrombolytic therapy...
January 2018: Interventional cardiology clinics
https://www.readbyqxmd.com/read/29157525/transcatheter-tricuspid-valve-replacement
#20
REVIEW
Amar Krishnaswamy, Jose Navia, Samir R Kapadia
Tricuspid regurgitation (TR) is a common entity, most commonly functional in nature due to right-sided dysfunction in the setting of concomitant cardiac disease or pulmonary hypertension. Patients living with TR often experience numerous limitations as a result of right-sided heart failure symptoms, including functional decline, frequent hospitalizations, liver failure, and kidney failure. Furthermore, patients with significant TR demonstrate worse survival, although a cause-and-effect relationship has not been proven...
January 2018: Interventional cardiology clinics
journal
journal
53856
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"